Schonfeld Strategic Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $68.2K | Sell |
|
|||||
|
2023
Q3 | $1.34M | Sell |
|
|||||
|
2023
Q2 | $4.68M | Buy |
|
|||||
|
2023
Q1 | $848K | Buy |
|
|||||
|
2022
Q4 | $372K | Sell |
|
|||||
|
2022
Q3 | $1.64M | Sell |
|
|||||
|
2022
Q2 | $2.15M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $2.4M | Sell |
|
|||||
|
2021
Q3 | $3.31M | Sell |
|
|||||
|
2021
Q2 | $4.87M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $373K | Sell |
|
|||||
|
2020
Q3 | $297K | Sell |
|
|||||
|
2020
Q2 | $637K | Sell |
|
|||||
|
2020
Q1 | $1.28M | Sell |
|
|||||
|
2019
Q4 | $3.63M | Sell |
|
|||||
|
2019
Q3 | $9.74M | Sell |
|
|||||
|
2019
Q2 | $22.7M | Buy |
|
|||||
|
2019
Q1 | $11.8M | Buy |
|
|||||
|
2018
Q4 | $3.86M | Buy |
|
|||||
|
2018
Q3 | $2.57M | Sell |
|
|||||
|
2018
Q2 | $4.39M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $586K | Buy |
|